- Home
- ZVIA vs VRCA Comparison
ZVIA vs VRCA Comparison
Compare ZVIA & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZVIA | VRCA |
|---|---|---|
| Founded | 2007 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 96.4M | 87.5M |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ZVIA | VRCA |
|---|---|---|
| Price | $1.16 | $5.80 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $4.93 | ★ $17.00 |
| AVG Volume (30 Days) | ★ 513.9K | 107.5K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.88 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $161,259,000.00 | $35,577,000.00 |
| Revenue This Year | $8.33 | N/A |
| Revenue Next Year | $6.84 | $92.12 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 4.01 | ★ 370.22 |
| 52 Week Low | $1.11 | $0.39 |
| 52 Week High | $3.66 | $9.82 |
Technical Indicators
Market Signals| Indicator | ZVIA | VRCA |
|---|---|---|
| Relative Strength Index (RSI) | 35.33 | 54.14 |
| Support Level | $1.12 | $5.18 |
| Resistance Level | $2.76 | $6.48 |
| Average True Range (ATR) | 0.07 | 0.52 |
| MACD | 0.02 | 0.13 |
| Stochastic Oscillator | 25.00 | 72.66 |
Price Performance
Historical ComparisonAbout ZVIA Zevia PBC
Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.